Health & Biotech
Check out the latest Animal Health news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
News
Pampered pets continue to boost ASX pet stocks, reporting solid half yearly results
Health & Biotech
Stock Insiders: PharmAust’s subsidiary Epichem generates $3.5m in sales in FY2022
Experts
MoneyTalks: Why Red Leaf Securities reckons its time to pamper these ASX pet stocks
Health & Biotech
ScoPo’s Powerplays: All looking good on the ground for ASX health stocks
News
Pampered pooches: Which ASX stocks are riding the ‘humanisation of pets’ trend?
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
PharmAust expands canine trial of Monepantel to the US, expediting the close out of Phase 2 study
Health & Biotech
Similarities with our pets could offer giant breakthroughs in cancer research, says PharmAust
Health & Biotech
Stock Insiders: Legendary Canadian cannabis entrepreneur Bruce Linton on the sector’s future and why he’s backing Creso Pharma
Health & Biotech
PharmAust pushes forward with lead drug monepantel, four clinical trials to rollout
Health & Biotech
Apiam makes two key acquisitions as it grows foothold in regional veterinary market
Health & Biotech
Apiam expands presence in national animal health market with Equine Clinic acquisition
Health & Biotech
PharmAust expands studies in NZ, one step closer towards a Phase 3 trial for canine cancer
Health & Biotech
Apiam confirms APVMA approval for a critical new vaccine in a major breakthrough for Australian cattle health
Health & Biotech
PharmAust makes important progress during quarter ahead of multiple clinical trials of lead drug, monepantel
Health & Biotech
Apiam expands presence in key regional Victorian hub with acquisition of Horsham Veterinary Hospital
Health & Biotech
Dairy and mixed clinics boost Apiam’s solid start to FY22 as vet network closes key acquisitions
Health & Biotech
PharmAust’s lead drug MPL step closer to COVID-19 and MND human clinical trials
Health & Biotech
PharmAust doubles life expectancy of pet dogs with cancer, a major step towards commercialisation
Health & Biotech
Merck’s COVID-19 breakthrough in the US gives boost to ASX- listed PharmAust
The Secret Broker
The Secret Broker: Possessions gonna possess
Health & Biotech
PharmAust reward loyal shareholders with attractively priced option offer
Health & Biotech
From companion to large animal care – here’s how Apiam’s knowledge of rural vet clinics is driving growth
Health & Biotech
Vets are four times more likely to die of suicide. Here’s how Apiam is tackling a troubling mental health crisis
Health & Biotech
Dairy and mixed clinics boost Apiam FY21 profits as the vet network continues regional expansion
Health & Biotech
More resources, better vets, booming profits; How Apiam is changing the game with Australia’s largest regional vet network
Health & Biotech
Apiam is staying busy in M&A as it builds a dominant regional vet network – here’s how the numbers stack up
Health & Biotech
PharmAust makes progress in the quarter as it lays the foundation for commercialisation
Stockhead TV
Q-Wrapz: Oriel Morrison interviews Roger Aston, executive chairman of PharmAust Ltd (ASX:PAA)
Health & Biotech
PharmAust files for patent on lead drug monepantel to fight viral diseases
Health & Biotech
PharmAust flags good news on key stability test for Monepantel treatment
Health & Biotech
Apiam expands equine footprint and boosts Qld growth network with new acquisition, shares climb
Health & Biotech
PharmAust achieves successful Phase II trials on monepantel for canine cancer, shares jump
Health & Biotech
Apiam delivers major boost for Australia’s $5bn pork industry with Data Pig technology platform
Health & Biotech
Executive insights: How Apiam is capitalising on the major opportunity in ‘greenfield’ vet clinics
Health & Biotech
Apiam expands dominant footprint in regional markets with major Queensland acquisition
Health & Biotech
Creso Pharma expands into Eastern Europe with animal product launch in Poland
Health & Biotech
Creso Pharma launches hemp-based product for swine, enters the lucrative livestock market
Health & Biotech
The federal government just prioritised vets on its skilled migrant list – here’s why Apiam is set to be a major beneficiary
Health & Biotech
PharmAust calls on experienced exec in push to commercialise its drug for canine cancer
Health & Biotech
Apiam gains traction with analysts, institutional investors and strategic partners as regional growth plans accelerate
News
There’s never been a more exciting time to be a pet care stock; and the ASX cohort just grew further
Health & Biotech
PharmAust passes critical milestone in Phase II study of Monepantel, sets eyes on Phase III
Health & Biotech
Big investors pile in to Apiam’s $6m funding round as its regional growth strategy accelerates
Health & Biotech
Apiam shares are up more than 30pc in 2021, as corporate investors back its aggressive growth strategy
Health & Biotech
How Apiam is using technology to revolutionise regional vet care
Health & Biotech
Creso Pharma makes plans to enter US market with new partnership
Load More
